Calculating Disease-Based Medical Care Expenditure Indexes for Medicare Beneficiaries: A Comparison of Method and Data Choices

Anne E. Hall, Tina Highfill

Chapter in NBER book Measuring and Modeling Health Care Costs (2018), Ana Aizcorbe, Colin Baker, Ernst Berndt, and David Cutler, editors (p. 113 - 141)
Conference held October 18-19, 2013
Published in February 2018 by University of Chicago Press
© 2018 by the National Bureau of Economic Research
in NBER Book Series Studies in Income and Wealth

Disease‐based medical care expenditure indexes are currently of interest to measurement economists and have been the subject of several recent papers. These papers, however, produced widely different results for medical care inflation and also varied in the datasets and methods used, making comparison difficult. In this paper, using two data sources and two different methods for calculating expenditure indexes for the Medicare population, we compare the indexes produced and establish some results that will help guide policymakers in choosing indexes for this population. We compare two methods: the primary diagnosis method and a regression‐based method. The former is preferable because of its transparency but makes stringent demands of the data. We find that when the methods are applied to the same datasets, the primary diagnosis method produces higher average annual aggregate growth rates. The difference implies that the regression‐based method should therefore be employed with caution and only when necessary. We also compare medical care expenditure indexes produced from the Medicare Current Beneficiary Survey and the Medical Expenditure Panel Survey. The MEPS is the only dataset with diagnoses attached to drug events, which significantly affects the resulting indexes. On balance, however, the MCBS is probably the preferable dataset for Medicare beneficiaries because of its greater sample size and its inclusion of nursing home residents. The optimal index may be a hybrid of the primary diagnosis method applied to Medicare claims and a regression‐based index for pharmaceutical spending. We discuss further avenues for research, such as comparing our results with indexes created with commercial groupers, and what data to use for Medicare private plan enrollees.

This chapter is no longer available for free download, since the book has been published. To obtain a copy, you must buy the book.
Order from

Machine-readable bibliographic record - MARC, RIS, BibTeX

This chapter first appeared as NBER working paper w19720, Calculating Disease-Based Medical Care Expenditure Indexes for Medicare Beneficiaries: A Comparison of Method and Data Choices, Anne E. Hall, Tina Highfill
Users who downloaded this chapter also downloaded* these:
Rosen, Aizcorbe, Highfill, Chernew, Liebman, Ghosh, and Cutler Attribution of Health Care Costs to Diseases: Does the Method Matter?
Bradley and Baker The Simultaneous Effects of Obesity, Insurance Choice, and Medical Visit Choice on Health Care Costs
Glazer, McGuire, and Shi Risk Adjustment of Health Plan Payments to Correct Inefficient Plan Choice from Adverse Selection
Franco, Goldman, Leive, and McFadden A Cautionary Tale in Comparative Effectiveness Research: Pitfalls and Perils of Observational Data Analysis
Karaca-Mandic, Abraham, Simon, and Feldman Going into the Affordable Care Act: Measuring the Size, Structure, and Performance of the Individual and Small Group Markets for Health Insurance
NBER Videos

National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email:

Contact Us